Procter & Gamble reported fourth quarter net sales of $21.2 billion, a 2% increase year-over-year, and GAAP EPS of $1.26. Core EPS came in at $1.43, a 3% decrease from the prior year but slightly ahead of analyst estimates.

Key Highlights

  • Organic sales were flat year-over-year, a significant miss from the 3% growth analysts expected, as pricing and volume each had a neutral impact on results.
  • The Beauty segment was a bright spot with 4% organic sales growth, while Health Care (-1%) and Baby, Feminine & Family Care (-2%) saw declines.
  • Core operating margin declined by 130 basis points versus the prior year, reflecting increased marketing reinvestments and unfavorable product mix that were only partially offset by productivity savings.
  • For fiscal 2027, the company guided to organic sales growth of 1% to 3% and core EPS growth of in-line to 3%, signaling continued cost headwinds of approximately $1 billion after-tax.